APA (7th ed.) Citation

Dickter, J. K., Martin, A. L., Ho, S., Ross, J. A., & Shouse, G. P. (2021). Ibalizumab‐uiyk as a bridge therapy for a patient with drug‐resistant HIV‐1 infection receiving chemotherapy: A case report. Journal of Clinical Pharmacy & Therapeutics, 46(4), 1185. https://doi.org/10.1111/jcpt.13411

Chicago Style (17th ed.) Citation

Dickter, Jana K., Abigail L. Martin, Stephanie Ho, Justine A. Ross, and Geoffrey P. Shouse. "Ibalizumab‐uiyk as a Bridge Therapy for a Patient with Drug‐resistant HIV‐1 Infection Receiving Chemotherapy: A Case Report." Journal of Clinical Pharmacy & Therapeutics 46, no. 4 (2021): 1185. https://doi.org/10.1111/jcpt.13411.

MLA (9th ed.) Citation

Dickter, Jana K., et al. "Ibalizumab‐uiyk as a Bridge Therapy for a Patient with Drug‐resistant HIV‐1 Infection Receiving Chemotherapy: A Case Report." Journal of Clinical Pharmacy & Therapeutics, vol. 46, no. 4, 2021, p. 1185, https://doi.org/10.1111/jcpt.13411.